郭雪, 于中兰, 魏丽娟, 郑磊, 刘俊田. 乳腺原发性血管肉瘤8例临床分析[J]. 中国肿瘤临床, 2011, 38(1): 42-45 . DOI: 10.3969/j.issn.1000-8179.2011.01.010
引用本文: 郭雪, 于中兰, 魏丽娟, 郑磊, 刘俊田. 乳腺原发性血管肉瘤8例临床分析[J]. 中国肿瘤临床, 2011, 38(1): 42-45 . DOI: 10.3969/j.issn.1000-8179.2011.01.010

乳腺原发性血管肉瘤8例临床分析

  • 摘要: 目的:探讨乳腺原发性血管肉瘤的临床病理特征, 诊治方法及预后。方法: 回顾性分析天津医科大学附属肿瘤医院自1975年12月至2009年8月收治的8例乳腺原发性血管肉瘤的临床病理资料。结果: 本组8例患者, 仅1例为男性, 中位年龄44.5岁 (17~60岁)。均以乳腺肿物为首发症状入院, 肿物中位直径6.0cm (2.5~8.0cm), 肿物表面皮肤均伴有不同程度颜色改变。均以手术为首选治疗, 术后病理: 低分化血管肉瘤1例, 中分化血管肉瘤4例, 高分化血管肉瘤3例, 均未见明显淋巴结转移。术后4例行辅助化疗, 1例复发后行放疗及热疗。4例术后有局部复发, 首次复发中位时间为31个月 (12~48个月), 3例发生远处转移,转移部位包括肺、 骨、 肝、 卵巢、颅脑及全身皮肤等, 发生转移中位时间为84个月 (54~291个月)。术后中位随访时间54个月 (7~300个月),其中已明确死亡4例, 2例无瘤生存, 2例失访。结论: 乳腺原发性血管肉瘤是临床上极为罕见的一种预后较差的恶性肿瘤, 肿物表面皮肤多伴有颜色改变, 临床表现常与良性肿瘤相混淆, 辅助检查无明显特征性表现, 术后容易发生复发及转移, 并以血行转移为主, 淋巴转移少见。目前治疗仍以手术为主, 主要是乳房切除术, 且至今尚无足够资料证实术后辅助放化疗可使患者生存获益。

     

    Abstract: Clinical Analysis of 8 Patients with Primary Angiosarcoma of the BreastXue GUO1, Zhonglan YU2, Lijuan WEI1, Lei ZHENG1, Juntian LIU1Correspondence to: LIU Juntian, e-mail:ljt641024@yahoo.cn1Department Ⅱof Breast Cancer, Cancer Institute and Hospital of Tianjin Medical University, Tianjin 300060, China2Cangxian Hospital, Cangzhou 061000, Hebei, ChinaAbstract Objective: To investigate the clinicopathologic charateristics, diagnosis, treatment, and prognosis of primaryangiosarcoma of the breast (PAB). Methods: The clinicopathologic data of 8 PAB patients treated in our hospital betweenDecember 1975 and August 2009 were retrospectively analyzed. Results: Of the 8 patients in the study one was male. Themedian age was 44.5 years (ranged 20-60). All patients were admitted to our hospital with breast masses as the first clini-cal symptom. The median diameter of the tumors was 6.0 cm (2.5 ~ 8 cm). The skin over the surface of the tumor dis-played color changes of different degrees. Surgery was the preferred treatment. Postoperative pathologic results showedthat poorly or moderately differentiated angiosarcoma was seen in one case, angiosarcoma of moderate differentiation wasseen in 4 cases, and well-differentiated tumor was seen in 3 cases. No obvious lymph-node metastasis was found. Postop-erative adjuvant chemotherapy was conducted in 4 cases, and radiotherapy and hyperthermia were administered in one ofthe 8 cases. Local recurrence occurred in 4 cases after surgery, and the median time to the first recurrence was 31 months(12~48 months). Distant metastases occurred in 3 of the 8 cases, with the sites of metastasis including lung, bone, liver,ovary, head and skin. The median time to metastasis was 84 months (54~291). A postoperative follow-up with mediantime of 54 months (7 ~300 months) showed 4 cases had died, 2 cases had disease-free survival, and 2 cases were lost tofollow up. Conclusion: Primary angiosarcoma of the breast is a rare malignant tumor with poor clinical prognosis. The skinover the surface of the tumor displays color changes, and the clinical manifestations are often confused with those of be-nign tumors. Recurrence and metastasis after surgery frequently occurred. Hematogenous metastasis is more commonthan lymphatic metastasis. Currently the major treatment for PAB is surgery with mastectomy. Patient survival is not in-creased after treatment with adjuvant chemotherapy and radiotherapy.Keywords Angiosarcoma of the breast; Therapy; Recurrence; Prognosis

     

/

返回文章
返回